Keywords: PFS، بقای پیشرفت بدون; CLM, colorectal liver metastases; OS, overall survival; PFS, progression-free survival; PVE, portal vein embolization
مقالات ISI PFS، بقای پیشرفت بدون (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: PFS، بقای پیشرفت بدون; Age; Clinical feature; Outcome; Skull base chordomaCI, Confidence interval; K-M, Kaplan-Meier; KPS, Karnofsky Performance Status; MR, Magnetic resonance; OC, Occipitocervical; OS, Overall survival; PFS, Progression-free survival; REN, Signal intensity rat
Keywords: PFS، بقای پیشرفت بدون; AC, appendiceal cancer; CRS, cytoreductive surgery; DSS, disease-specific survival; GSEA, Gene Set Enrichment Analysis; HIPEC, hyperthermic intraperitoneal chemotherapy; LFC, log fold change; LGA, low-grade appendiceal; PFS, progression-free survival; PSD
Keywords: PFS، بقای پیشرفت بدون; DC-CIK, dendritic cells co-cultured with cytokine-induced killer cells; NSCLC, non-small-cell lung cancer; RCT, randomized controlled trial; PFS, progression-free survival; OS, overall survival; ORR, objective response rates; DCR, disease control rate; HR
Keywords: PFS، بقای پیشرفت بدون; HGG, high-grade glioma; BVZ, bevacizumab; CPT11, irinotecan; FSRT, fractionated stereotactic radiotherapy; RANO, revised Assessment in Neuro-Oncology; MRI, magnetic resonance imaging; OS, overall survival; PFS, progression-free survival; TMZ, temozolomide
Keywords: PFS، بقای پیشرفت بدون; Astrocytoma; IDH1; Outcomes; SurgeryAII, WHO grade II astrocytomas; ECOG, Eastern Cooperative Oncology Group; IDH1, Isocitrate dehydrogenase 1; MRI, Magnetic resonance imaging; OS, Overall survival; PFS, Progression-free survival; WHO, World Health Organi
Keywords: PFS، بقای پیشرفت بدون; biomarkers; cardiovascular agents; clinical trials; drug costs; pharmacological; policyAD, adaptive design; NME, new molecular entity; PFS, progression-free survival; ROI, return on investment
Keywords: PFS، بقای پیشرفت بدون; SCLC, small-cell lung carcinomas; NSCLC, non-small cell lung carcinomas; MM, malignant mesothelioma; AdenoCA, adenocarcinomas; SQCLC, squamous cell lung cancers; LCAC, large cell anaplastic carcinomas; OS, overall survival; PFS, progression-free survival;
Keywords: PFS، بقای پیشرفت بدون; kidney neoplasms; thrombosis; neoplasm staging; prognosis; carcinoma, renal cellCSS, cancer specific survival; IVC, inferior vena cava; MRV, main renal vein; NVM, negative vascular margin; PFS, progression-free survival; PVM, positive vascular margin; RCC
Significant Role of Lifetime Cigarette Smoking in Worsening Bladder Cancer and Upper Tract Urothelial Carcinoma Prognosis: A Meta-Analysis
Keywords: PFS، بقای پیشرفت بدون; urinary bladder neoplasms; carcinoma; transitional cell; smoking; prognosis; meta-analysisBC, bladder cancer; DSS, disease specific survival; MIBC, muscle invasive bladder cancer; NMIBC, nonmuscle invasive bladder cancer; PFS, progression-free survival; R
P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer
Keywords: PFS، بقای پیشرفت بدون; ALK, anaplastic lymphoma kinase; TKI, tyrosine kinase inhibitor; P-gp, P-glycoprotein; ROS1, v-ros avian ur2 sarcoma virus oncogene homolog 1; PFS, progression-free survival; ORR, overall response rate; EGFR, epidermal growth factor receptor; BBB, blood–b
Endoscopic Endonasal Management of Metastatic Lesions of the Anterior Skull Base: Case Series and Literature Review
Keywords: PFS، بقای پیشرفت بدون; Endoscopic endonasal approach; Parasellar metastasis; Sellar metastasis; Skull baseCSF, Cerebrospinal fluid; DI, Diabetes insipidus; GTR, Gross total resection; PFS, Progression-free survival; SBM, Skull base metastases
Surgical Outcomes in the Management of Isolated Nodal Recurrences: A Multicenter, International Retrospective Cohort
Keywords: PFS، بقای پیشرفت بدون; kidney; carcinoma; renal cell; lymph node excision; recurrence; nephrectomyNED, no disease evidence; PFS, progression-free survival; RCC, renal cell carcinoma; RPLND, retroperitoneal lymph node dissection
Prognostic evaluation of PET/CT in residual post-chemotherapy masses in patients with diffuse large B-cell lymphoma and its impact on survival
Keywords: PFS، بقای پیشرفت بدون; PET/CT, positron emission tomography/computed tomography; CRu, complete remission/unconfirmed; DLBCL, diffuse large B-cell lymphoma; OAS, overall survival; PFS, progression-free survival; CR, complete remission; SUV, standard uptake value; LDH, lactate de
Prognostic value of coexistence of abnormal expression of micro-RNA-200b and cyclic adenosine monophosphate-responsive element-binding protein 1 in human astrocytoma
Keywords: PFS، بقای پیشرفت بدون; CREB-1, cAMP-responsive element-binding protein 1; KPS, Karnofsky performance score; OS, overall survival; PFS, progression-free survival; qRT-PCR, quantitative real-time polymerase chain reactionAstrocytoma; CREB-1; Micro-RNA-200b; Tumor progression; Pro
MicroRNAs as prognostic markers in ovarian cancer
Keywords: PFS، بقای پیشرفت بدون; OC, Ovarian cancer; OS, overall survival; miRNAs, microRNAs; HG-SOC, high-grade serous OC; TCGA, The Cancer Genome Atlas; SNPs, single nucleotide polymorphisms; PFS, progression-free survival; FFPE, formalin-fixed paraffin-embedded; EMT, epithelial-to-mes
Predictors of Outcomes in Patients with Primary Retroperitoneal Dedifferentiated Liposarcoma Undergoing Surgery
Keywords: PFS، بقای پیشرفت بدون; DDLPS, dedifferentiated liposarcoma; DRFS, distant recurrence-free survival; FNCLCC, French Federation of Cancer Centers Sarcoma Group; HR, hazard ratio; LRFS, local recurrence-free survival; OS, overall survival; PFS, progression-free survival; RP, retro
Atypical Meningioma: A Study of Prognostic Factors
Keywords: PFS، بقای پیشرفت بدون; Adjuvant radiotherapy; Atypical meningioma; Prognostic factorsHPF, High-power field; OAS, Overall survival; PFS, Progression-free survival; RT, Radiotherapy; WHO, World Health Organization
A phase II study of combination chemotherapy using docetaxel and irinotecan for TC-refractory or TC-resistant ovarian carcinomas (GOGO-OV2 study) and for primary clear or mucinous ovarian carcinomas (GOGO-OV3 Study)
Keywords: PFS، بقای پیشرفت بدون; Ovarian cancer; Refractory; Resistant; Clear cell; Mucinous; Docetaxel; Irinotecan; TCCR, complete response; OS, overall survival; PD, progressive disease; PFS, progression-free survival; PR, partial response; RR, responsive rate; SD, stable disease; TC,
Phosphorylation of 4E-BP1 predicts sensitivity to everolimus in gastric cancer cells
Keywords: PFS، بقای پیشرفت بدون; 4E-BP1, 4E-binding protein 1; DCR, disease control rate; mTOR, mammalian target of rapamycin; mTORC1, mTOR complex 1; mTORC2, mTOR complex 2; PFS, progression-free survival; PI3K, phosphoinositide 3-kinase; S6K1, S6 kinase 1mTOR inhibitor; Gastric cancer;
Bevacizumab-Associated Fistula Formation in Postoperative Colorectal Cancer Patients
Keywords: PFS، بقای پیشرفت بدون; CRC, colon and rectal cancer; FOLFOX, leucovorin, fluorouracil, and oxaliplatin; OS, overall survival; PFS, progression-free survival; VEGF, vascular endothelial growth factor
Assessment of the prognostic significance of endoglin (CD105) in clear cell renal cell carcinoma using automated image analysis
Keywords: PFS، بقای پیشرفت بدون; ccRCC, clear cell renal cell carcinoma; PFS, progression-free survival; MOD, mean optical density; IMVD, intratumoral microvascular densityRenal cell carcinoma; Prognosis; CD31; Endoglin; Angiogenesis
The Effect of Sunitinib on Primary Renal Cell Carcinoma and Facilitation of Subsequent Surgery
Keywords: PFS، بقای پیشرفت بدون; sunitinib; carcinoma; renal cell; preoperative period; neoadjuvant therapy; tumor burdenCT, computerized tomography; ECOG, Eastern Cooperative Oncology Group; IVC, inferior vena cava; PFS, progression-free survival; QD, daily; RCC, renal cell carcinoma; R
Overexpression of ubiquitous mitochondrial creatine kinase (uMtCK) accelerates tumor growth by inhibiting apoptosis of breast cancer cells and is associated with a poor prognosis in breast cancer patients
Keywords: PFS، بقای پیشرفت بدون; uMtCK, ubiquitous mitochondrial creatine kinase; CK, creatine kinase; BCa, breast cancer; PFS, progression-free survival; OS, overall survival; IDC-NOS, the invasive ductal carcinomas of breast tissue, not otherwise specified; ΔΨm, mitochondrial transmemb
Biomarkers predicting tumor response and evasion to anti-angiogenic therapy
Keywords: PFS، بقای پیشرفت بدون; DBP, diastolic blood pressure; PFS, progression-free survival; OS, overall survival; VEGF, vascular endothelial growth factor; PIGF, Placental growth factor; VEGFR, vascular endothelial growth factor receptor; sVEGFR, soluble vascular endothelial growth f
The Value of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy
Keywords: PFS، بقای پیشرفت بدون; kidney; carcinoma; renal cell; neoplasm metastasis; nephrectomy; mortalityCN, cytoreductive nephrectomy; CT, computerized tomography; mRCC, metastatic RCC; OS, overall survival; PFS, progression-free survival; RCC, renal cell carcinoma; VEGF, vascular end
Expression of estrogen receptor beta predicts a clinical response and longer progression-free survival after treatment with EGFR–TKI for adenocarcinoma of the lung
Keywords: PFS، بقای پیشرفت بدون; EGFR, epidermal growth factor receptor; TKI, tyrosine kinase inhibitor; ER, estrogen receptor; PFS, progression-free survival; PS, performance status; RECIST, response evaluation criteria in solid tumors; OS, overall survival; IHC, immunohistochemical; p-
Clinical Reliability of the 2004 WHO Histological Classification System Compared With the 1973 WHO System for Ta Primary Bladder Tumors
Keywords: PFS، بقای پیشرفت بدون; urinary bladder; urothelium; carcinoma; World Health Organization; neoplasm recurrence; localCIS, carcinoma in situ; NMIBC, nonmuscle invasive bladder cancer; PFS, progression-free survival; PUNLMP, papillary urothelial neoplasm of low malignant potential
Long-Term Results of Hepatectomy for Patients with Alveolar Echinococcosis: A Single-Center Experience
Keywords: PFS، بقای پیشرفت بدون; ABZ, albendazole; AE, alveolar echinococcosis; BMZ, benzimidazoles; MBZ, mebendazole; OS, overall survival; PFS, progression-free survival; US, ultrasonography
Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer
Keywords: PFS، بقای پیشرفت بدون; Epithelial ovarian cancer; DNA methylation; DOK1; Tumor suppressor; Progression-free survival; DNA microarraysEOC, epithelial ovarian cancer; PFS, progression-free survival; IHC, immunohistochemistry; CT, chemotherapy; IPA, Ingenuity Pathway Analysis; TMA
Which patients should be operated on after induction chemotherapy for N2 non–small cell lung cancer? Analysis of a 7-year experience in 175 patients
Keywords: PFS، بقای پیشرفت بدون; 10CT, computed tomography; EORTC, European Organisation for Research and Treatment of Cancer; MST, median survival time; NSCLC, non–small cell lung cancer; PET, positron emission tomography; PFS, progression-free survival
The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy
Keywords: PFS، بقای پیشرفت بدون; AUC, Area under the curve; OS, Overall survival; DFI, Disease free interval; PFS, Progression-free survival; SCC, Squamous cell carcinomaRecurrent cervical cancer; Carboplatin–paclitaxel; Nedaplatin; Cisplatin; Radiotherapy
Nonseminomatous germ cell tumors: Assessing the need for postchemotherapy contralateral pulmonary resection in patients with ipsilateral complete necrosis
Keywords: PFS، بقای پیشرفت بدون; CI, confidence interval; GCT, germ cell tumor; IGCCCG, International Germ Cell Consensus Classification; NSGCT, nonseminomatous germ cell tumor; OS, overall survival; PFS, progression-free survival; RPLND, retroperitonal lymph node dissection10
Intraluminal implantation of radioactive stents for treatment of primary carcinomas of the peripancreatic-head region: a pilot study
Keywords: PFS، بقای پیشرفت بدون; CBD, common bile duct; EHBDC, extrahepatic bile-duct carcinoma; IBT, interstitial brachytherapy; IDUS, intraductal US; ILBT, intraluminal brachytherapy; KPS, Karnofsky performance status; PD, pancreatic duct; PFS, progression-free survival; PTV, planning
Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer
Keywords: PFS، بقای پیشرفت بدون; Ovarian cancer; Human kallikreins; Chromosomal rearrangementsKLK, human tissue kallikrein protein; KLK, human tissue kallikrein gene; ELISA, enzyme-linked immunosorbent assay; PFS, progression-free survival; OS, overall survival; FIGO, Fédération Internat
Under Diagnosis and Over Diagnosis of Prostate Cancer
Keywords: PFS، بقای پیشرفت بدون; prostate; prostatic neoplasms; diagnosis; mass screening; prostate-specific antigenDRE, digital rectal examination; PCa, prostate cancer; PFS, progression-free survival; PSA, prostate specific antigen; R1, positive surgical margins; RRP, radical retropubi
Prostate Specific Antigen Density Correlates With Features of Prostate Cancer Aggressiveness
Keywords: PFS، بقای پیشرفت بدون; prostate-specific antigen; prostatic neoplasms; disease progressionDRE, digital rectal examination; PFS, progression-free survival; PSA, prostate specific antigen; PSAD, prostate specific antigen density; PSAV, prostate specific antigen velocity
Adjuvant Weekly Docetaxel for Patients With High Risk Prostate Cancer After Radical Prostatectomy: A Multi-Institutional Pilot Study
Keywords: PFS، بقای پیشرفت بدون; prostate; prostatic neoplasms; drug therapy; prostatectomy; mortalityCT, computerized tomography; PFS, progression-free survival; PSA, prostate specific antigen; RP, radical prostatectomy; Rw′, weighted risk of recurrence; SWOG, Southwest Oncology Group
The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
Keywords: PFS، بقای پیشرفت بدون; bladder neoplasms; reoperation; disease-free survivalBCG, bacillus Calmette-Guerin; Cis, carcinoma in situ; MMC, mitomycin C; OS, overall survival; PFS, progression-free survival; ReTUR, repeat transurethral resection; RFS, recurrence-free survival; TCC,
Characteristics of Patients With Familial Versus Sporadic Prostate Cancer
Keywords: PFS، بقای پیشرفت بدون; prostatic neoplasms; heredity; family health; disease progression; prostatectomyCaP, prostate cancer; HPC1, hereditary prostate cancer 1 [locus]; PFS, progression-free survival; PSA, prostate specific antigen; RRP, radical retropubic prostatectomy
The Bicalutamide 150 Mg Early Prostate Cancer Program: Findings of the North American Trial at 7.7-Year Median Followup
Keywords: PFS، بقای پیشرفت بدون; prostate; androgen antagonists; prostatic neoplasms; clinical trials; bicalutamideEPC, early prostate cancer; NQ, not quantifiable (below 0.2 ng/ml limit of quantification); OS, overall survival; PFS, progression-free survival; PSA, prostate specific anti
Impact of Patient Age at Treatment on Outcome Following Radical Retropubic Prostatectomy for Prostate Cancer
Keywords: PFS، بقای پیشرفت بدون; prostate; prostatic neoplasms; prostatectomy; age groups; mortalitybPFS, biochemical PFS; c-index, concordance index; CSS, cancer specific survival; PFS, progression-free survival; PSA, prostate specific antigen; RRP, radical retropubic prostatectomy; sPF